Maryann Redlinger

Author PubWeight™ 10.51^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase II trial of sorafenib in advanced thyroid cancer.	J Clin Oncol	2008	5.31
2	A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.	Clin Cancer Res	2008	1.99
3	Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.	Cancer Chemother Pharmacol	2009	0.93
4	Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study.	Cancer Chemother Pharmacol	2011	0.84
5	Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer.	Clin Cancer Res	2002	0.81
6	Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.	Cancer	2013	0.78
7	Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.	Cancer Chemother Pharmacol	2003	0.75
8	A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine.	Cancer Chemother Pharmacol	2004	0.75